ABSTRACT
Apocrine hidrocystomas are mostly found on the cheeks and eyelids but also on the scalp and neck. The age distribution is from 30 to 70 years old. We report a case of an apocrine hidrocystoma on the genitalia of a 9-year-old girl.
Subject(s)
Genitalia/pathology , Hidrocystoma/pathology , Sweat Gland Neoplasms/pathology , Child , Diagnosis, Differential , Female , HumansABSTRACT
A 73-year-old male with diabetes mellitus had been treated with insulin for six years. He developed a solid mass on his left lateral of the abdomen at the insulin injection site. A firm subcutaneous mass with dark-red erythema was overlaid by dark-brown keratinized plaques. On histological examination of the mass, keratin proliferation and epidermal papilloma were observed. There were four previously reported cases of acanthosis nigricans that were considered to be caused by continuous injections of insulin. Using immunohistochemistry, in our case the findings were positive in the basal epithelial and prickle cell layers when the patient's lesion was dyed with insulin-like growth factor (IGF)-1 antibody. The coexistence of dermal IGF-1 receptor and acanthosis nigricans found in our patient has not been reported previously, to our knowledge.
Subject(s)
Acanthosis Nigricans/chemically induced , Acanthosis Nigricans/pathology , Insulin/administration & dosage , Insulin/adverse effects , Acanthosis Nigricans/metabolism , Aged , Humans , Injections, Subcutaneous , Male , Receptor, IGF Type 1/metabolismABSTRACT
Various therapies have been tried for psoriasis. In Japan, biologics began to be used for psoriasis treatment in January 2010. Their clinical efficacy is well known, but biologics cannot be used in all psoriasis patients for reasons such as side-effects and cost. It is necessary to evaluate the effect of long-term psoriasis treatment, but there have been no reports evaluating long-term treatment. Therefore, the outcomes of patients who had been treated at the Tokai University Hospital for more than 5 years, before biological agents were released, were examined. Three categories, classified by initial severity, changes in severity by method of treatment and background characteristics, were investigated. In conclusion, cases of long-term treatment with a combination of topical corticosteroid and topical vitamin D3 analog or oral cyclosporin were found to be effective therapies. Patients with a history of diabetes mellitus or cardiovascular disease of psoriasis were likely to be treatment resistant.
Subject(s)
Cholecalciferol/therapeutic use , Cyclosporine/therapeutic use , Dermatologic Agents/therapeutic use , Etretinate/therapeutic use , Glucocorticoids/therapeutic use , Phototherapy/methods , Psoriasis/drug therapy , Administration, Oral , Administration, Topical , Adolescent , Adult , Aged , Aged, 80 and over , Child , Cholecalciferol/adverse effects , Cholecalciferol/analogs & derivatives , Cyclosporine/adverse effects , Dermatologic Agents/adverse effects , Drug Combinations , Etretinate/adverse effects , Female , Follow-Up Studies , Glucocorticoids/adverse effects , Humans , Japan , Male , Middle Aged , Severity of Illness Index , Time Factors , Treatment Outcome , Young AdultABSTRACT
Chromomycosis is a chronic fungal disease of the skin and subcutaneous tissues caused by a group of dematiaceous black fungi. Small lesions can be removed with excision, but other cases are difficult to treat. We report a case of chromomycosis caused by Fonsecaea pedrosoi (F. pedrosoi). The case involved a 74-year-old man, who had noted a lesion on the back of the right thigh, that was gradually enlarging and reaching up to 30 cm in diameter, in 20-years. From microscopic examination, sclerotic cells were seen. We diagnosed this case as chromomycosis caused by F. pedrosoi on mycological examination. The patient was initially treated with oral terbinafine (250 mg/day) as the lesion was very large. After the 18 months treatment, the size of the lesion reduced to 1 cm, then the remaining lesion was excised.
